Atlas Trials

A Multicenter Study to Evaluate Next-Generation Sequencing (NGS) Testing and Monitoring of B-Cell Recovery to Guide Management Following Chimeric Antigen Receptor T-cell (CART) Induced Remission in Children and Young Adults With B Lineage Acute Lymph...

Clinical trial NCT05621291 · RECRUITING

Trial details

NCT number
NCT05621291
Sponsor
National Cancer Institute (NCI)
Status
RECRUITING
Phase
Not Applicable
Study type
INTERVENTIONAL
B-AllAcute Lymphoblastic Leukemia
Start date
2026-08-23
Primary completion
2026-12-31
Enrollment
60

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.